- €48.23m
- €64.10m
- €112.60m
- 60
- 44
- 31
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 91.1 | 77.6 | 84.7 | 98.3 | 113 |
Cost of Revenue | |||||
Gross Profit | 21.8 | 14.5 | 15.7 | 18 | 26.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 86.8 | 81.5 | 85.2 | 97.5 | 115 |
Operating Profit | 4.3 | -3.93 | -0.476 | 0.762 | -2.72 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.25 | -5.42 | 0.285 | -0.563 | -3.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.93 | -4.58 | -0.068 | -1.18 | -5.71 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.81 | -4.74 | -0.255 | -1.4 | -5.83 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.81 | -4.74 | -0.255 | -1.4 | -5.83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.308 | -0.522 | 0.044 | -0.146 | -0.201 |
Dividends per Share |